About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch

Biovault Technical

About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch
6 May 2026
Quality & Safety, Regulatory Partnerships, Cellular Therapies, Innovation, Ethical Practices
Sarah Conway
Donor lymphocyte infusions: from reactive ...

Donor lymphocyte infusions (DLI) and clinical readiness. Discover Biovault’s pre-prepared DLI processing and storage approach for faster access and reduced risk.

Donor lymphocyte infusions: from reactive intervention to clinical readiness
30 March 2026
Industry Events, Company News, Cellular Therapies
Sarah Conway
EBMT 2026: 5 Insights Shaping the Future of ...

5 key takeaways from EBMT 2026, from expanded cord blood and JACIE quality to regulation, infrastructure and the future of cell therapy.

EBMT 2026: 5 Insights Shaping the Future of Cell Therapy
10 February 2026
Cellular Therapies, Innovation
Sarah Conway
The Evolution of Cell Therapy Part 3: Immune ...

Explore how PBSCs enabled CAR-T and immune effector cell therapies, and how Biovault supports safe processing, storage and delivery of advanced cellular medicines.

The Evolution of Cell Therapy Part 3: Immune Effector Cell Therapies
1 December 2025
Cellular Therapies
Sarah Conway
The Evolution of Cell Therapy Part 2: ...

How peripheral blood stem cells became the preferred source for transplantation, and how Biovault supports PBSC collection pathways through compliant processing and storage.

The Evolution of Cell Therapy Part 2: Peripheral Blood Stem Cells
29 September 2025
Innovation
Sarah Conway
Engineering Cellular Therapy Tools: How ...

How Biovault Technical engineered new cryoshipper racks and CRF freezer racks to enhance safety, usability and compliance for cellular therapies.

Engineering Cellular Therapy Tools: How Biovault Built Better Cryo Racks
Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships

Preventing catastrophic failure in biobank systems

Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships
Preventing catastrophic failure in biobank systems

Following the publication of a report on the devastating cryogenic freezer failure at the Karolinska Institutet (KI) in Sweden in December 2023, we scrutinise our systems and offer some support. 

Sarah Conway
13 March 2024
Cellular Therapies, Quality & Safety, Company News

Elevating Patient Care: Biovault's Expertise in Peripheral Blood Stem Cell (PBSC) Solutions

Sarah Conway
13 March 2024
Cellular Therapies, Quality & Safety, Company News
Elevating Patient Care: Biovault's Expertise in Peripheral Blood Stem Cell (PBSC) Solutions

In 2023, Biovault worked alongside 6 NHS trusts to process 1,552 cellular therapy products and to release 753, making us a leading provider of PBSC services.

Sarah Conway
10 February 2024
Company News, Ethical Practices

Women and Girls in (biomedical) Science

Sarah Conway
10 February 2024
Company News, Ethical Practices
Women and Girls in (biomedical) Science

Everyone should have full and equal access to science education and careers, but do they? February 11th is the United Nations International Day of Women and Girls in Science. We check up on equality of access in the UK and at Biovault.

Sarah Conway
18 December 2023
Company News

Looking ahead to 2024

Sarah Conway
18 December 2023
Company News
Looking ahead to 2024

As 2023 draws to a close, we look ahead to three innovations set to transform the way we serve our community, clients and ecosystem in 2024.

Sarah Conway
16 November 2023
Sustainability, Innovation, Ethical Practices

Biovault Cuts Emissions by 11.3% in First Year of Net Zero Pledge

Sarah Conway
16 November 2023
Sustainability, Innovation, Ethical Practices
Biovault Cuts Emissions by 11.3% in First Year of Net Zero Pledge

Biobanking saves lives every day, but it is also an energy-intensive operation that can emit thousands of kilograms of CO2E* per week. As the UK’s ethical tissue bank, Biovault is leading the way in reducing emissions as part of a pledge to Make it Net Zero.

Sarah Conway
2 November 2023
Educational Resources

Introduction to Allograft Types

Sarah Conway
2 November 2023
Educational Resources
Introduction to Allograft Types

With so many types of allografts now available to doctors and patients, and with innovation rapidly enhancing allograft products, we get back to basics with a guide to the main types of allografts processed, stored and released by Biovault.

Newer Posts
Back to Top
Biovault Technical Ltd, Plymouth International Medical & Technology Park, 24 Brest Road, Derriford, Plymouth, PL6 5XP, United Kingdom+44 1752 753720info@biovaulttechnical.co.uk

address

Biovault Technical
24 Brest Road
Plymouth, PL6 5XP
View on map

TELEPHONE

+44 (0)1752 753720

enquiries

info@biovaulttechnical.co.uk

careers

COOKIE POLICY

Privacy Policy

CONTACT